2 Firms Will Steer FibroGen Stockholder Suit In Chancery
Johnson Fistel LLP and Glancy Prongay & Murray LLP have been appointed lead counsel in a consolidated derivative suit filed by FibroGen Inc. stockholders asserting breach of fiduciary duty and insider...To view the full article, register now.
Already a subscriber? Click here to view full article